CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-111286 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,400
Total Value
$152,019.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Shares | โ | Mar 14, 2026 | Exercise/Conversion | 8,125 | โ | โ | 16,293 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | Mar 16, 2026 | Sale | 3,150 | $48.26 | $152,019.00 | 13,143 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Mar 14, 2026 | Exercise/Conversion | 8,125 | โ | โ | 24,375 | Direct | โ | View Details |